Arnold DL - Search Results

1

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. Among authors: arnold dl. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.

2

Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease.

Arnold DL, Matthews PM, Francis G, Antel J. Arnold DL, et al. Magn Reson Med. 1990 Apr;14(1):154-9. doi: 10.1002/mrm.1910140115. Magn Reson Med. 1990. PMID: 2161982

3

Neuroimaging in multiple sclerosis.

Francis GS, Evans AC, Arnold DL. Francis GS, et al. Among authors: arnold dl. Neurol Clin. 1995 Feb;13(1):147-71. Neurol Clin. 1995. PMID: 7739501 Review.

4

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.

Matthews PM, Pioro E, Narayanan S, De Stefano N, Fu L, Francis G, Antel J, Wolfson C, Arnold DL. Matthews PM, et al. Among authors: arnold dl. Brain. 1996 Jun;119 ( Pt 3):715-22. doi: 10.1093/brain/119.3.715. Brain. 1996. PMID: 8673485

5

The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis.

Arnold DL, Wolinsky JS, Matthews PM, Falini A. Arnold DL, et al. J Neurol Neurosurg Psychiatry. 1998 May;64 Suppl 1:S94-101. J Neurol Neurosurg Psychiatry. 1998. PMID: 9647294 Free article. Review.

6

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.

Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, Arnold DL. Matthews PM, et al. Among authors: arnold dl. Semin Neurol. 1998;18(3):327-36. doi: 10.1055/s-2008-1040884. Semin Neurol. 1998. PMID: 9817537 Review.

7

Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume.

Prat A, Pelletier D, Duquette P, Arnold DL, Antel JP. Prat A, et al. Among authors: arnold dl. Ann Neurol. 2000 Feb;47(2):234-7. Ann Neurol. 2000. PMID: 10665495

8

Proton MR spectroscopy in multiple sclerosis.

Arnold DL, De Stefano N, Narayanan S, Matthews PM. Arnold DL, et al. Neuroimaging Clin N Am. 2000 Nov;10(4):789-98 ,ix-x. Neuroimaging Clin N Am. 2000. PMID: 11359725 Review.

9

The lesions of multiple sclerosis.

Paty DW, Arnold DL. Paty DW, et al. Among authors: arnold dl. N Engl J Med. 2002 Jan 17;346(3):199-200. doi: 10.1056/NEJM200201173460311. N Engl J Med. 2002. PMID: 11796856 No abstract available.

10

MRI in the diagnosis and management of multiple sclerosis.

Arnold DL, Matthews PM. Arnold DL, et al. Neurology. 2002 Apr 23;58(8 Suppl 4):S23-31. doi: 10.1212/wnl.58.8_suppl_4.s23. Neurology. 2002. PMID: 11971123 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters